Using Glycosylated Hemoglobin to Define the Metabolic Syndrome in United States Adults
- Kwok Leung Ong, MPHIL1,
- Annette W.K. Tso, MD1,2,
- Karen S.L. Lam, MD1,2,
- Stacey S. Cherny, PHD3,4,
- Pak Chung Sham, MD3,4,5 and
- Bernard M.Y. Cheung, PHD1,2
- 1Department of Medicine, University of Hong Kong, Hong Kong, China;
- 2Research Centre of Heart, Brain, Hormone and Healthy Aging, University of Hong Kong, Hong Kong, China;
- 3Department of Psychiatry, University of Hong Kong, Hong Kong, China;
- 4State Key Laboratory of Brain and Cognitive Sciences, University of Hong Kong, Hong Kong, China;
- 5Genome Research Centre, University of Hong Kong, Hong Kong, China.
- Co-corresponding authors: Annette W.K. Tso, awktso{at}hku.hk and Bernard M.Y. Cheung, mycheung{at}hku.hk.
Abstract
OBJECTIVE To compare the use of GHb and fasting plasma glucose (FPG) to define the metabolic syndrome (MetS).
RESEARCH DESIGN AND METHODS Data from the U.S. National Health and Nutrition Examination Survey 1999–2006 were used. MetS was defined using the consensus criteria in 2009. Raised blood glucose was defined as either FPG ≥100 mg/dl (5.6 mmol/l) or GHb ≥5.7%.
RESULTS In 2003–2006, there was 91.3% agreement between GHb and FPG when either was used to define MetS. The agreement was good irrespective of age, sex, race/ethnicity, BMI, and diabetes status (≥87.4%). Similar results were found in 1999–2002. Among subjects without diabetes, only the use of GHb alone, but not FPG, resulted in significant association with cardiovascular diseases (odds ratio 1.45, P = 0.005).
CONCLUSIONS Using GHb instead of FPG to define MetS is feasible. It also identifies individuals with increased cardiovascular risk.
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- © 2010 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
